IIA
TMO icon

Integral Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Integral Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Buy
2,729
+223
+9% +$107K 0.3% 66
2026
Q1 		$1.23M Sell
2,506
-256
-9% -$139K 0.31% 65
2025
Q4 		$1.6M Buy
2,762
+396
+17% +$224K 0.4% 55
2025
Q3 		$1.15M Buy
2,366
+66
+3% +$30.7K 0.31% 64
2025
Q2 		$933K Sell
2,300
-1,281
-36% -$536K 0.27% 68
2025
Q1 		$1.78M Buy
3,581
+997
+39% +$540K 0.57% 34
2024
Q4 		$1.34M Buy
2,584
+135
+6% +$74.2K 0.44% 47
2024
Q3 		$1.51M Buy
2,449
+64
+3% +$37.9K 0.51% 41
2024
Q2 		$1.31M Buy
2,385
+619
+35% +$355K 0.48% 42
2024
Q1 		$1.02M Buy
1,766
+378
+27% +$212K 0.42% 46
2023
Q4 		$737K Buy
1,388
+46
+3% +$22.3K 0.47% 46
2023
Q3 		$679K Buy
1,342
+28
+2% +$14.9K 0.48% 45
2023
Q2 		$686K Sell
1,314
-4
-0.3% -$2.16K 0.46% 43
2023
Q1 		$760K Sell
1,318
-23
-2% -$13K 0.54% 33
2022
Q4 		$738K Sell
1,341
-29
-2% -$15.4K 0.57% 34
2022
Q3 		$695K Sell
1,370
-185
-12% -$104K 0.57% 41
2022
Q2 		$845K Sell
1,555
-74
-5% -$40.7K 0.72% 28
2022
Q1 		$962K Buy
1,629
+247
+18% +$142K 0.6% 39
2021
Q4 		$922K Buy
+1,382
New +$863K 0.66% 34

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Integral Investment Advisors's TMO Position: Q2 2026 in Review

Integral Investment Advisors increased its Thermo Fisher Scientific (TMO) stake by 8.9% in Q2 2026, buying an estimated $107K and bringing the position to 2,729 shares worth $1.37M. The position accounts for 0.3% of the portfolio, ranked #66.

Integral Investment Advisors first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.78M in Q1 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Integral Investment Advisors held 2,729 shares of Thermo Fisher Scientific worth $1.37M as of Q2 2026.
  • Integral Investment Advisors bought 223 Thermo Fisher Scientific shares in Q2 2026, an estimated $107K.
  • Thermo Fisher Scientific made up 0.3% of Integral Investment Advisors's portfolio in Q2 2026, its #66 holding.
  • Integral Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • Integral Investment Advisors's Thermo Fisher Scientific position peaked at $1.78M in Q1 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Integral Investment Advisors's 13F filing for Q2 2026, filed 7 Jul 2026.